Since co-founding Athersys in 1995, Dr. Mays has directed the drug discovery applications of Athersys' cell biological platform technologies. Currently, Dr. Mays is the Head of Neurosciences and the Senior Director of Regenerative Medicine and is focused on the development of Athersys' novel human stem cell product MultiStem® and its applications in Regenerative Medicine, with a specific focus on injuries and diseases affecting the central nervous system. He received his B.S. from Carnegie Mellon in 1987, and his Ph.D. from Stanford University in Molecular and Cellular Physiology. He subsequently studied at the University of Utrecht, the Weizmann Institute and at the University of California, San Francisco. He is currently an adjunct professor at Case Western Reserve University and on faculty at the Center for Stem Cell and Regenerative Medicine and the National Center for Regenerative Medicine. Since co-founding Athersys in 1995, Dr. Mays has directed the drug discovery applications of Athersys' cell biological platform technologies. Currently, Dr. Mays is the Head of Neurosciences and the Senior Director of Regenerative Medicine and is focused on the development of Athersys' novel human stem cell product MultiStem® and its applications in Regenerative Medicine, with a specific focus on injuries and diseases affecting the central nervous system. He received his B.S. from Carnegie Mellon in 1987, and his Ph.D. from Stanford University in Molecular and Cellular Physiology. He subsequently studied at the University of Utrecht, the Weizmann Institute and at the University of California, San Francisco. He is currently an adjunct professor at Case Western Reserve University and on faculty at the Center for Stem Cell and Regenerative Medicine and the National Center for Regenerative Medicine.

Genetics and Molecular Biology